{
  "costs": {
    "exit_bps": 10,
    "entry_bps": 10,
    "rationale": "Illustrative investor transaction costs, not verified account fees; no actual transaction authorized."
  },
  "facts": {
    "cash": {
      "value": 110.1,
      "rationale": "September cash, not claimed current November bank cash.",
      "source_ids": [
        "q4"
      ]
    },
    "price": {
      "value": 97.58,
      "rationale": "Observed ordinary CAD price; no trade assumed.",
      "source_ids": [
        "quote"
      ]
    },
    "food_sales": {
      "value": 17399.1,
      "rationale": "FY2026 food sales.",
      "source_ids": [
        "q4"
      ]
    },
    "lease_cash": {
      "value": 341.6,
      "rationale": "Recognized principal 285.4 plus interest 56.2; variable rent already expensed.",
      "source_ids": [
        "q4"
      ]
    },
    "funded_debt": {
      "value": 3186.7,
      "rationale": "Current plus long-term funded debt; recognized leases excluded under cash-rent treatment.",
      "source_ids": [
        "q4"
      ]
    },
    "common_shares": {
      "value": 208.4818744619799,
      "rationale": "September outside shares plus outstanding option treasury-stock proxy at the reference quote plus PSUs. No post-quarter NCIB share-count inference.",
      "source_ids": [
        "q4",
        "quote"
      ]
    },
    "sublease_cash": {
      "value": 113.7,
      "rationale": "Finance-sublease principal 99.9 plus interest 13.8; operating rental income already in operating profit.",
      "source_ids": [
        "q4"
      ]
    },
    "pharmacy_sales": {
      "value": 5149.6,
      "rationale": "FY2026 pharmacy sales.",
      "source_ids": [
        "q4"
      ]
    },
    "strike_tax_rate": {
      "value": 0.265,
      "rationale": "Statutory tax proxy to translate lost after-tax profit into operating profit.",
      "source_ids": [
        "q4"
      ]
    },
    "strike_after_tax": {
      "value": 97,
      "rationale": "Management estimate of FY2026 lost profit, not cash receivable or refund.",
      "source_ids": [
        "q4"
      ]
    },
    "cash_ebitda_before_lease": {
      "value": 1994.7,
      "rationale": "EBIT plus D&A, restructuring and impairment, less asset gains; retains economic compensation expense.",
      "source_ids": [
        "q4"
      ]
    },
    "operating_working_capital": {
      "value": 858.4,
      "rationale": "Selected trade receivables, inventories and prepaid expenses less trade payables and deferred revenue; not the complete cash-flow movement.",
      "source_ids": [
        "q4"
      ]
    }
  },
  "units": "millions",
  "ticker": "MRU",
  "history": {
    "impairment": {
      "value": 33.9,
      "rationale": "FY2026 cash-flow statement; CAD millions. Positive asset gains, working-capital use and tax paid are deducted in the reconciliation.",
      "source_ids": [
        "q4"
      ]
    },
    "taxes_paid": {
      "value": 361.6,
      "rationale": "FY2026 cash-flow statement; CAD millions. Positive asset gains, working-capital use and tax paid are deducted in the reconciliation.",
      "source_ids": [
        "q4"
      ]
    },
    "asset_gains": {
      "value": 32.1,
      "rationale": "FY2026 cash-flow statement; CAD millions. Positive asset gains, working-capital use and tax paid are deducted in the reconciliation.",
      "source_ids": [
        "q4"
      ]
    },
    "pretax_income": {
      "value": 1177.6,
      "rationale": "FY2026 cash-flow statement; CAD millions. Positive asset gains, working-capital use and tax paid are deducted in the reconciliation.",
      "source_ids": [
        "q4"
      ]
    },
    "restructuring": {
      "value": 25.7,
      "rationale": "FY2026 cash-flow statement; CAD millions. Positive asset gains, working-capital use and tax paid are deducted in the reconciliation.",
      "source_ids": [
        "q4"
      ]
    },
    "lease_interest": {
      "value": 56.2,
      "rationale": "FY2026 cash-flow statement; CAD millions. Positive asset gains, working-capital use and tax paid are deducted in the reconciliation.",
      "source_ids": [
        "q4"
      ]
    },
    "lease_principal": {
      "value": 285.4,
      "rationale": "FY2026 cash-flow statement; CAD millions. Positive asset gains, working-capital use and tax paid are deducted in the reconciliation.",
      "source_ids": [
        "q4"
      ]
    },
    "capital_spending": {
      "value": 456.6,
      "rationale": "FY2026 cash-flow statement; CAD millions. Positive asset gains, working-capital use and tax paid are deducted in the reconciliation.",
      "source_ids": [
        "q4"
      ]
    },
    "net_finance_cost": {
      "value": 164.4,
      "rationale": "FY2026 cash-flow statement; CAD millions. Positive asset gains, working-capital use and tax paid are deducted in the reconciliation.",
      "source_ids": [
        "q4"
      ]
    },
    "sublease_interest": {
      "value": 13.8,
      "rationale": "FY2026 cash-flow statement; CAD millions. Positive asset gains, working-capital use and tax paid are deducted in the reconciliation.",
      "source_ids": [
        "q4"
      ]
    },
    "debt_interest_cash": {
      "value": 134.9,
      "rationale": "FY2026 cash-flow statement; CAD millions. Positive asset gains, working-capital use and tax paid are deducted in the reconciliation.",
      "source_ids": [
        "q4"
      ]
    },
    "share_compensation": {
      "value": 14.3,
      "rationale": "FY2026 cash-flow statement; CAD millions. Positive asset gains, working-capital use and tax paid are deducted in the reconciliation.",
      "source_ids": [
        "q4"
      ]
    },
    "sublease_principal": {
      "value": 99.9,
      "rationale": "FY2026 cash-flow statement; CAD millions. Positive asset gains, working-capital use and tax paid are deducted in the reconciliation.",
      "source_ids": [
        "q4"
      ]
    },
    "operating_cash_flow": {
      "value": 1561.4,
      "rationale": "FY2026 cash-flow statement; CAD millions. Positive asset gains, working-capital use and tax paid are deducted in the reconciliation.",
      "source_ids": [
        "q4"
      ]
    },
    "pension_cash_timing": {
      "value": 44.1,
      "rationale": "FY2026 cash-flow statement; CAD millions. Positive asset gains, working-capital use and tax paid are deducted in the reconciliation.",
      "source_ids": [
        "q4"
      ]
    },
    "working_capital_use": {
      "value": 130.1,
      "rationale": "FY2026 cash-flow statement; CAD millions. Positive asset gains, working-capital use and tax paid are deducted in the reconciliation.",
      "source_ids": [
        "q4"
      ]
    },
    "depreciation_amortization": {
      "value": 625.2,
      "rationale": "FY2026 cash-flow statement; CAD millions. Positive asset gains, working-capital use and tax paid are deducted in the reconciliation.",
      "source_ids": [
        "q4"
      ]
    }
  },
  "periods": [
    "2027-11-18",
    "2028-11-18",
    "2029-11-18",
    "2030-11-18",
    "2031-11-18",
    "2032-11-18",
    "2033-11-18",
    "2034-11-18",
    "2035-11-18",
    "2036-11-18"
  ],
  "sources": {
    "q4": {
      "url": "https://www.corpo.metro.ca/userfiles/file/PDF/Rapport-trimestriel/2026/2026-Fourth-Quarter-Results.pdf",
      "kind": "primary",
      "sha256": "27c1d588195bd51b4e695325cb119baa9e38f76c24100d9c559a7a9881ca0a93",
      "locator": "METRO fourth-quarter FY2026 report, November 18; PDF pp. 5\u201310 and 19\u201326; unaudited full-year financials through September 26",
      "published_on": "2026-11-18"
    },
    "quote": {
      "url": "https://finance.yahoo.com/quote/MRU.TO/",
      "kind": "market_data",
      "sha256": "bef2631b24d6abfa464d39f8fe5143509313749afabefc74b6007b3d6826a5c3",
      "locator": "Dated ordinary CAD MRU.TO quote: November 18 close C$97.58; provider beta is historical, not a forward risk estimate",
      "published_on": "2026-11-18"
    },
    "annual": {
      "url": "https://corpo.metro.ca/userfiles/file/PDF/Rapport-Annuel/2025/en/annual_report_2025_EN.pdf",
      "kind": "primary",
      "sha256": "495a02f576b89fe566cc1e8611f8a5177999a789fcedacd58d5026ada454d0cf",
      "locator": "METRO FY2025 audited annual report; lease notes PDF pp. 65\u201367. Available on official IR page November 18, 2026; this availability bound is not a claimed publication day.",
      "published_on": "2026-11-18"
    }
  },
  "currency": "CAD",
  "research": {
    "method": "Ten-year nominal CAD enterprise cash-flow valuation after net lease cash and funded reinvestment. Funded debt is deducted once. The twelve-month target rolls remaining operating value and the projected cash balance forward; dividends are paid from that cash bridge.",
    "catalysts": [
      {
        "by_date": "2027-02-28",
        "description": "Review food sales recovery and pharmacy growth at the next reported quarterly results; this is an analyst review window, not a promised publication date."
      },
      {
        "by_date": "2028-11-30",
        "description": "Test store-conversion execution, capital intensity and whether recurring cost savings are becoming visible."
      }
    ],
    "falsifiers": [
      {
        "by_date": "2027-11-30",
        "description": "Persistently negative food comparable sales, loss of customers after the strike, or higher capital spending without improved cash conversion would weaken the base recovery case."
      },
      {
        "by_date": "2028-11-30",
        "description": "Stronger traffic recovery, sustained pharmacy growth and lower required reinvestment would challenge a cautious valuation."
      }
    ],
    "lease_basis": "Deduct recognized gross rent and add finance-sublease receipts; operating rental income and variable rent remain in recurring EBITDA. Exclude lease liabilities and sublease receivable value from the equity bridge. Retain compensation expense; no future buyback-driven EPS growth.",
    "limitations": "FY2026 results are unaudited. Cash, funded debt and share-award disclosures are September balances; diluted closing shares use a treasury-stock proxy at the November quote. Maintenance capital, tax depreciation, lease renewal and minority distributions are estimates. Annual cash buffers do not test monthly liquidity. Terminal value is material, and no probabilities are assigned.",
    "variant_view": "Recurring demand and pharmacy growth support earnings, but normalized cash conversion, store investment and the price paid determine prospective returns. Strike recovery is gradual lost-profit recovery, not reimbursed cash.",
    "discount_basis": "Base CAD WACC 6.5% is an analyst required-return judgment: assumed normalized cost of equity 6.75%, marginal funded-debt cost 4.75%, statutory tax 26.5%, and about 13.5% funded-debt weight imply about 6.31%, rounded up for execution uncertainty. Provider beta 0.317 is historical and does not set a forward required return. Bear 8% and bull 5.25% are conditional joint risk stresses. No component is presented as an observed bond quote or consensus target.",
    "five_year_assessment": "Conditional five-year stock returns include dividends and illustrative investor costs. They do not establish prospective outperformance of MSCI ACWI IMI CAD net total return over rolling five-year periods. XIC remains the Canadian-sleeve comparator only. No benchmark forecast or trade instruction is implied."
  },
  "scenarios": {
    "base": {
      "periods": [
        {
          "food_growth": {
            "value": 0.03,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.25,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.2735364344729407,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.045,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 0.25,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08816186254639957,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.0475,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.016,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 0,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 4,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.03,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.253,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.349618101531352,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.045,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 0.5,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08786186254639956,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.0475,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.016,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 7.5,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 4,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.03,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.256,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.428336619432606,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.045,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 0.75,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08756186254639957,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.0475,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.016,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 15,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 4,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.03,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.259,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.509787041739387,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.045,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 0.75,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08726186254639956,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.0475,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.016,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 15,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 4,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.03,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.262,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.5940679912829414,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.045,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 0.75,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08696186254639957,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.0475,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.016,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 15,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 4,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.028,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.265,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.674215309850452,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.039999999999999994,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 0.75,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08696186254639957,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.0475,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.016,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 15,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 4,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.026,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.265,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.749605371459603,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.035,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 0.75,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08696186254639957,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.0475,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.016,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 15,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 4,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.024,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.265,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.81963962022623,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.03,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 0.75,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08696186254639957,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.0475,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.016,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 15,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 4,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.022,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.265,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.8837542075947797,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.024999999999999998,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 0.75,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08696186254639957,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.0475,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.016,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 15,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 4,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.02,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.265,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.941429291746675,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.02,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 0.75,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08696186254639957,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.0475,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.016,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 15,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 4,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        }
      ],
      "dividends": [
        {
          "value": 1.63,
          "rationale": "Annualized current declared quarterly dividend and assumed subsequent growth; no future buybacks or issuance.",
          "source_ids": [
            "q4"
          ]
        },
        {
          "value": 1.6788999999999998,
          "rationale": "Annualized current declared quarterly dividend and assumed subsequent growth; no future buybacks or issuance.",
          "source_ids": [
            "q4"
          ]
        },
        {
          "value": 1.7292669999999999,
          "rationale": "Annualized current declared quarterly dividend and assumed subsequent growth; no future buybacks or issuance.",
          "source_ids": [
            "q4"
          ]
        },
        {
          "value": 1.78114501,
          "rationale": "Annualized current declared quarterly dividend and assumed subsequent growth; no future buybacks or issuance.",
          "source_ids": [
            "q4"
          ]
        },
        {
          "value": 1.8345793603,
          "rationale": "Annualized current declared quarterly dividend and assumed subsequent growth; no future buybacks or issuance.",
          "source_ids": [
            "q4"
          ]
        }
      ],
      "minimum_cash": {
        "value": 100,
        "rationale": "Analyst annual cash buffer; annual model cannot establish intra-year liquidity.",
        "source_ids": [
          "q4"
        ]
      },
      "discount_rate": {
        "value": 0.065,
        "rationale": "Analyst nominal CAD WACC. Required return stress includes uncertain equity risk, competitive intensity and debt refinancing; not consensus target calibration.",
        "source_ids": [
          "q4",
          "quote"
        ]
      },
      "terminal_growth": {
        "value": 0.02,
        "rationale": "Analyst perpetual nominal growth, with funded fixed investment and working capital.",
        "source_ids": [
          "q4"
        ]
      },
      "terminal_drivers": {
        "food_growth": {
          "value": 0.02,
          "rationale": "Terminal normalization: growth equals capitalization growth; no separate repeated recovery or savings addback.",
          "source_ids": [
            "q4"
          ]
        },
        "other_margin": {
          "value": 0,
          "rationale": "Terminal normalization: growth equals capitalization growth; no separate repeated recovery or savings addback.",
          "source_ids": [
            "q4"
          ]
        },
        "cash_tax_rate": {
          "value": 0.265,
          "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
          "source_ids": [
            "q4"
          ]
        },
        "noncommon_cash": {
          "value": 3.0002578775816087,
          "rationale": "Terminal minority cash proxy grows with sales.",
          "source_ids": [
            "q4"
          ]
        },
        "pharmacy_growth": {
          "value": 0.02,
          "rationale": "Terminal normalization: growth equals capitalization growth; no separate repeated recovery or savings addback.",
          "source_ids": [
            "q4"
          ]
        },
        "strike_recovery": {
          "value": 0,
          "rationale": "Terminal normalization: growth equals capitalization growth; no separate repeated recovery or savings addback.",
          "source_ids": [
            "q4"
          ]
        },
        "base_cash_margin": {
          "value": 0.0909219296520279,
          "rationale": "Recovered profit and recurring savings embedded once in normalized terminal margin.",
          "source_ids": [
            "q4"
          ]
        },
        "lease_cash_ratio": {
          "value": 0.015149432118037848,
          "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
          "source_ids": [
            "q4"
          ]
        },
        "debt_interest_rate": {
          "value": 0.0475,
          "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
          "source_ids": [
            "q4"
          ]
        },
        "sublease_cash_ratio": {
          "value": 0.0050424192968996,
          "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
          "source_ids": [
            "q4"
          ]
        },
        "working_capital_ratio": {
          "value": 0.03806871349567824,
          "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
          "source_ids": [
            "q4"
          ]
        },
        "tax_depreciation_ratio": {
          "value": 0.0155,
          "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
          "source_ids": [
            "q4"
          ]
        },
        "maintenance_capex_ratio": {
          "value": 0.016,
          "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
          "source_ids": [
            "q4"
          ]
        },
        "annual_savings_after_tax": {
          "value": 0,
          "rationale": "Terminal normalization: growth equals capitalization growth; no separate repeated recovery or savings addback.",
          "source_ids": [
            "q4"
          ]
        },
        "incremental_sales_to_fixed_capital": {
          "value": 4,
          "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
          "source_ids": [
            "q4"
          ]
        }
      }
    },
    "bear": {
      "periods": [
        {
          "food_growth": {
            "value": 0.01,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.25,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.2320485792972544,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.03,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 0.08333333333333333,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08766186254639957,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.055,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.017,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 0,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 3,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.01,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.253,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.264719101766399,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.03,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 0.16666666666666666,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08686186254639956,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.055,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.017,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 3.75,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 3,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.01,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.256,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.29802683056052,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.03,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 0.25,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08606186254639957,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.055,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.017,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 7.5,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 3,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.01,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.259,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.331987452775876,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.03,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 0.25,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08526186254639957,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.055,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.017,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 7.5,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 3,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.01,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.262,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.3666170918306784,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.03,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 0.25,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08446186254639956,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.055,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.017,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 7.5,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 3,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.01,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.265,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.399602508719269,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.026000000000000002,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 0.25,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08446186254639956,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.055,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.017,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 7.5,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 3,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.01,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.265,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.4307696935805954,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.022,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 0.25,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08446186254639956,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.055,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.017,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 7.5,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 3,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.01,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.265,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.4599633407091774,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.018000000000000002,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 0.25,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08446186254639956,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.055,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.017,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 7.5,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 3,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.01,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.265,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.487049922764392,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.013999999999999999,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 0.25,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08446186254639956,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.055,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.017,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 7.5,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 3,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.01,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.265,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.5119204219920364,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.01,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 0.25,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08446186254639956,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.055,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.017,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 7.5,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 3,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        }
      ],
      "dividends": [
        {
          "value": 1.63,
          "rationale": "Annualized current declared quarterly dividend and assumed subsequent growth; no future buybacks or issuance.",
          "source_ids": [
            "q4"
          ]
        },
        {
          "value": 1.63,
          "rationale": "Annualized current declared quarterly dividend and assumed subsequent growth; no future buybacks or issuance.",
          "source_ids": [
            "q4"
          ]
        },
        {
          "value": 1.63,
          "rationale": "Annualized current declared quarterly dividend and assumed subsequent growth; no future buybacks or issuance.",
          "source_ids": [
            "q4"
          ]
        },
        {
          "value": 1.63,
          "rationale": "Annualized current declared quarterly dividend and assumed subsequent growth; no future buybacks or issuance.",
          "source_ids": [
            "q4"
          ]
        },
        {
          "value": 1.63,
          "rationale": "Annualized current declared quarterly dividend and assumed subsequent growth; no future buybacks or issuance.",
          "source_ids": [
            "q4"
          ]
        }
      ],
      "minimum_cash": {
        "value": 100,
        "rationale": "Analyst annual cash buffer; annual model cannot establish intra-year liquidity.",
        "source_ids": [
          "q4"
        ]
      },
      "discount_rate": {
        "value": 0.08,
        "rationale": "Analyst nominal CAD WACC. Required return stress includes uncertain equity risk, competitive intensity and debt refinancing; not consensus target calibration.",
        "source_ids": [
          "q4",
          "quote"
        ]
      },
      "terminal_growth": {
        "value": 0.01,
        "rationale": "Analyst perpetual nominal growth, with funded fixed investment and working capital.",
        "source_ids": [
          "q4"
        ]
      },
      "terminal_drivers": {
        "food_growth": {
          "value": 0.01,
          "rationale": "Terminal normalization: growth equals capitalization growth; no separate repeated recovery or savings addback.",
          "source_ids": [
            "q4"
          ]
        },
        "other_margin": {
          "value": 0,
          "rationale": "Terminal normalization: growth equals capitalization growth; no separate repeated recovery or savings addback.",
          "source_ids": [
            "q4"
          ]
        },
        "cash_tax_rate": {
          "value": 0.265,
          "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
          "source_ids": [
            "q4"
          ]
        },
        "noncommon_cash": {
          "value": 2.5370396262119566,
          "rationale": "Terminal minority cash proxy grows with sales.",
          "source_ids": [
            "q4"
          ]
        },
        "pharmacy_growth": {
          "value": 0.01,
          "rationale": "Terminal normalization: growth equals capitalization growth; no separate repeated recovery or savings addback.",
          "source_ids": [
            "q4"
          ]
        },
        "strike_recovery": {
          "value": 0,
          "rationale": "Terminal normalization: growth equals capitalization growth; no separate repeated recovery or savings addback.",
          "source_ids": [
            "q4"
          ]
        },
        "base_cash_margin": {
          "value": 0.08613970695912831,
          "rationale": "Recovered profit and recurring savings embedded once in normalized terminal margin.",
          "source_ids": [
            "q4"
          ]
        },
        "lease_cash_ratio": {
          "value": 0.015149432118037848,
          "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
          "source_ids": [
            "q4"
          ]
        },
        "debt_interest_rate": {
          "value": 0.055,
          "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
          "source_ids": [
            "q4"
          ]
        },
        "sublease_cash_ratio": {
          "value": 0.0050424192968996,
          "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
          "source_ids": [
            "q4"
          ]
        },
        "working_capital_ratio": {
          "value": 0.03806871349567824,
          "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
          "source_ids": [
            "q4"
          ]
        },
        "tax_depreciation_ratio": {
          "value": 0.0155,
          "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
          "source_ids": [
            "q4"
          ]
        },
        "maintenance_capex_ratio": {
          "value": 0.017,
          "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
          "source_ids": [
            "q4"
          ]
        },
        "annual_savings_after_tax": {
          "value": 0,
          "rationale": "Terminal normalization: growth equals capitalization growth; no separate repeated recovery or savings addback.",
          "source_ids": [
            "q4"
          ]
        },
        "incremental_sales_to_fixed_capital": {
          "value": 3,
          "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
          "source_ids": [
            "q4"
          ]
        }
      }
    },
    "bull": {
      "periods": [
        {
          "food_growth": {
            "value": 0.04,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.25,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.295536434472941,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.055,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 0.5,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08846186254639957,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.0425,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.0155,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 0,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 5,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.04,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.253,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.3953088302208108,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.055,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 1,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08846186254639957,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.0425,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.0155,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 15,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 5,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.04,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.256,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.4995094234088886,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.055,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 1,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08846186254639957,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.0425,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.0155,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 15,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 5,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.04,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.259,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.6083393935233476,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.055,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 1,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08846186254639957,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.0425,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.0155,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 15,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 5,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.04,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.262,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.7220092900671804,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.055,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 1,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08846186254639957,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.0425,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.0155,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 15,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 5,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.037000000000000005,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.265,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.830603488557313,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.049,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 1,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08846186254639957,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.0425,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.0155,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 15,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 5,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.034,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.265,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 2.93304348289884,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.043000000000000003,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 1,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08846186254639957,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.0425,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.0155,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 15,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 5,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.031,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.265,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 3.028278532993366,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.037000000000000005,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 1,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08846186254639957,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.0425,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.0155,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 15,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 5,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.028000000000000004,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.265,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 3.115305430968817,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.031,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 1,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08846186254639957,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.0425,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.0155,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 15,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 5,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        },
        {
          "food_growth": {
            "value": 0.025,
            "rationale": "Analyst nominal sales growth, fading to terminal growth. First-year recovery is not guaranteed; recent food traffic remains weak.",
            "source_ids": [
              "q4"
            ]
          },
          "other_margin": {
            "value": 0,
            "rationale": "No additional margin adjustment.",
            "source_ids": [
              "q4"
            ]
          },
          "cash_tax_rate": {
            "value": 0.265,
            "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
            "source_ids": [
              "q4"
            ]
          },
          "noncommon_cash": {
            "value": 3.1931880667430375,
            "rationale": "Minority cash proxy based on 2.2m attributed earnings, grown with sales; no second book-NCI deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "pharmacy_growth": {
            "value": 0.025,
            "rationale": "Analyst nominal sales growth; pharmacy is more resilient but not assigned a separately disclosed margin.",
            "source_ids": [
              "q4"
            ]
          },
          "strike_recovery": {
            "value": 1,
            "rationale": "Level recovery of estimated lost strike profit; gradual, not a repeated growth rate or cash refund.",
            "source_ids": [
              "q4"
            ]
          },
          "base_cash_margin": {
            "value": 0.08846186254639957,
            "rationale": "FY2026 recurring pre-lease margin with explicit competitive compression; recovery and conversion savings modeled separately.",
            "source_ids": [
              "q4"
            ]
          },
          "lease_cash_ratio": {
            "value": 0.015149432118037848,
            "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
            "source_ids": [
              "q4"
            ]
          },
          "debt_interest_rate": {
            "value": 0.0425,
            "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
            "source_ids": [
              "q4"
            ]
          },
          "sublease_cash_ratio": {
            "value": 0.0050424192968996,
            "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
            "source_ids": [
              "q4"
            ]
          },
          "working_capital_ratio": {
            "value": 0.03806871349567824,
            "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
            "source_ids": [
              "q4"
            ]
          },
          "tax_depreciation_ratio": {
            "value": 0.0155,
            "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
            "source_ids": [
              "q4"
            ]
          },
          "maintenance_capex_ratio": {
            "value": 0.0155,
            "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
            "source_ids": [
              "q4"
            ]
          },
          "annual_savings_after_tax": {
            "value": 15,
            "rationale": "Fraction of management estimated 15m recurring net savings by end FY2028; staged timing, no second margin credit.",
            "source_ids": [
              "q4"
            ]
          },
          "incremental_sales_to_fixed_capital": {
            "value": 5,
            "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
            "source_ids": [
              "q4"
            ]
          }
        }
      ],
      "dividends": [
        {
          "value": 1.63,
          "rationale": "Annualized current declared quarterly dividend and assumed subsequent growth; no future buybacks or issuance.",
          "source_ids": [
            "q4"
          ]
        },
        {
          "value": 1.6952,
          "rationale": "Annualized current declared quarterly dividend and assumed subsequent growth; no future buybacks or issuance.",
          "source_ids": [
            "q4"
          ]
        },
        {
          "value": 1.7630080000000001,
          "rationale": "Annualized current declared quarterly dividend and assumed subsequent growth; no future buybacks or issuance.",
          "source_ids": [
            "q4"
          ]
        },
        {
          "value": 1.83352832,
          "rationale": "Annualized current declared quarterly dividend and assumed subsequent growth; no future buybacks or issuance.",
          "source_ids": [
            "q4"
          ]
        },
        {
          "value": 1.9068694528000003,
          "rationale": "Annualized current declared quarterly dividend and assumed subsequent growth; no future buybacks or issuance.",
          "source_ids": [
            "q4"
          ]
        }
      ],
      "minimum_cash": {
        "value": 100,
        "rationale": "Analyst annual cash buffer; annual model cannot establish intra-year liquidity.",
        "source_ids": [
          "q4"
        ]
      },
      "discount_rate": {
        "value": 0.0525,
        "rationale": "Analyst nominal CAD WACC. Required return stress includes uncertain equity risk, competitive intensity and debt refinancing; not consensus target calibration.",
        "source_ids": [
          "q4",
          "quote"
        ]
      },
      "terminal_growth": {
        "value": 0.025,
        "rationale": "Analyst perpetual nominal growth, with funded fixed investment and working capital.",
        "source_ids": [
          "q4"
        ]
      },
      "terminal_drivers": {
        "food_growth": {
          "value": 0.025,
          "rationale": "Terminal normalization: growth equals capitalization growth; no separate repeated recovery or savings addback.",
          "source_ids": [
            "q4"
          ]
        },
        "other_margin": {
          "value": 0,
          "rationale": "Terminal normalization: growth equals capitalization growth; no separate repeated recovery or savings addback.",
          "source_ids": [
            "q4"
          ]
        },
        "cash_tax_rate": {
          "value": 0.265,
          "rationale": "Normalized tax assumption fades from 25% to statutory 26.5%; no perpetual tax holiday.",
          "source_ids": [
            "q4"
          ]
        },
        "noncommon_cash": {
          "value": 3.2730177684116133,
          "rationale": "Terminal minority cash proxy grows with sales.",
          "source_ids": [
            "q4"
          ]
        },
        "pharmacy_growth": {
          "value": 0.025,
          "rationale": "Terminal normalization: growth equals capitalization growth; no separate repeated recovery or savings addback.",
          "source_ids": [
            "q4"
          ]
        },
        "strike_recovery": {
          "value": 0,
          "rationale": "Terminal normalization: growth equals capitalization growth; no separate repeated recovery or savings addback.",
          "source_ids": [
            "q4"
          ]
        },
        "base_cash_margin": {
          "value": 0.09311780236650617,
          "rationale": "Recovered profit and recurring savings embedded once in normalized terminal margin.",
          "source_ids": [
            "q4"
          ]
        },
        "lease_cash_ratio": {
          "value": 0.015149432118037848,
          "rationale": "Recognized rent renewed as a constant share of sales; variable and short-term rent remains inside base operating costs.",
          "source_ids": [
            "q4"
          ]
        },
        "debt_interest_rate": {
          "value": 0.0425,
          "rationale": "Analyst refinancing cost, not a traded bond quote. Funded debt held constant through maturities; no new borrowing benefit.",
          "source_ids": [
            "q4"
          ]
        },
        "sublease_cash_ratio": {
          "value": 0.0050424192968996,
          "rationale": "Finance-sublease cash renews with the business; no separate receivable value. Counterparty and renewal risk remain.",
          "source_ids": [
            "q4"
          ]
        },
        "working_capital_ratio": {
          "value": 0.03806871349567824,
          "rationale": "Selected FY2026 operating working-capital ratio; not assumed equal to annual cash-flow movement.",
          "source_ids": [
            "q4"
          ]
        },
        "tax_depreciation_ratio": {
          "value": 0.0155,
          "rationale": "Estimated non-lease tax deduction proxy; actual tax pools unavailable. Excludes ROU depreciation to avoid double deduction.",
          "source_ids": [
            "q4"
          ]
        },
        "maintenance_capex_ratio": {
          "value": 0.0155,
          "rationale": "Analyst sustaining allowance; issuer does not split maintenance and growth capital. Together with growth capital benchmarked to FY2026 all-in capex.",
          "source_ids": [
            "q4"
          ]
        },
        "annual_savings_after_tax": {
          "value": 0,
          "rationale": "Terminal normalization: growth equals capitalization growth; no separate repeated recovery or savings addback.",
          "source_ids": [
            "q4"
          ]
        },
        "incremental_sales_to_fixed_capital": {
          "value": 5,
          "rationale": "Analyst incremental sales/fixed investment ratio; terminal growth must fund the same capital rule.",
          "source_ids": [
            "q4"
          ]
        }
      }
    }
  },
  "as_of_date": "2026-11-18",
  "quote_date": "2026-11-18",
  "financial_date": "2026-09-26",
  "horizon_months": 12,
  "schema_version": "retail-fcff-v1",
  "lease_convention": "net-cash-rent-fcff-v1",
  "financial_currency": "CAD"
}
